Healthcare & Life Sciences
Repron Therapeutics
Repron Therapeutics is a Healthcare & Life Sciences startup, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Repron Therapeutics
Repron Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Developing therapeutics that silence transcription factors of oncogenes to treat cancer. Focused on creating novel drug candidates targeting transcriptional regulators implicated in oncogenesis.
Explore Repron Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.